JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.97B |
| 2 |
Vanguard Total Bond Market
BND
|
+$1.96B |
| 3 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.61B |
| 4 |
UnitedHealth
UNH
|
+$1.1B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.08B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.25B |
| 2 |
Centene
CNC
|
+$827M |
| 3 |
Amazon
AMZN
|
+$791M |
| 4 |
Texas Instruments
TXN
|
+$716M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$569M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.62% |
| 2 | Healthcare | 12.48% |
| 3 | Financials | 10.51% |
| 4 | Consumer Discretionary | 8.11% |
| 5 | Industrials | 7.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PTVE
4301
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $453K | ﹤0.01% |
51,859
-444,829
| -90% | -$4.62M |
|
4302
Anavex Life Sciences
AVXL
$298M
| $452K | ﹤0.01% |
43,721
+3,026
| +7% | +$31.9K |
|
4303
Turkcell
TKC
$4.75B
| $452K | ﹤0.01% |
169,838
+39,949
| +31% | +$109K |
|
4304
BayCom
BCML
$339M
| $451K | ﹤0.01% |
25,666
+6,169
| +32% | +$119K |
|
|
FNA
4305
DELISTED
Paragon 28, Inc.
FNA
| $451K | ﹤0.01% |
25,316
+543
| +2% | +$10K |
|
|
BNFT
4306
DELISTED
Benefitfocus, Inc.
BNFT
| $450K | ﹤0.01% |
70,958
-40,022
| -36% | -$297K |
|
4307
LegalZoom.com
LZ
$963M
| $449K | ﹤0.01% |
52,423
-156,067
| -75% | -$1.62M |
|
4308
Oil States International
OIS
$539M
| $446K | ﹤0.01% |
114,588
-108
| -0.1% | -$516 |
|
4309
CALL
Health Catalyst
HCAT
$139M
| $445K | ﹤0.01% |
+45,900
| New | +$608K |
|
|
APCA
4310
DELISTED
AP Acquisition Corp
APCA
| $445K | ﹤0.01% |
43,800
| – | – |
|
|
BOXD
4311
DELISTED
Boxed, Inc.
BOXD
| $444K | ﹤0.01% |
481,172
+43,641
| +10% | +$63.7K |
|
4312
First Trust Rising Dividend Achievers ETF
RDVY
$25.8B
| $443K | ﹤0.01% |
11,403
-1,091
| -9% | -$46.9K |
|
|
SHYF
4313
DELISTED
The Shyft Group
SHYF
| $443K | ﹤0.01% |
21,711
-9,875
| -31% | -$230K |
|
4314
Costamare
CMRE
$1.77B
| $442K | ﹤0.01% |
49,474
+796
| +2% | +$8.78K |
|
|
GPMT
4315
Granite Point Mortgage Trust
GPMT
$57.4M
| $442K | ﹤0.01% |
68,607
+20,344
| +42% | +$193K |
|
|
EBIX
4316
DELISTED
Ebix Inc
EBIX
| $442K | ﹤0.01% |
23,307
-71,165
| -75% | -$1.57M |
|
4317
DocGo
DCGO
$65.9M
| $440K | ﹤0.01% |
44,360
+949
| +2% | +$8.57K |
|
4318
PUT
Inovio Pharmaceuticals
INO
$113M
| $440K | ﹤0.01% |
21,250
| – | – |
|
4319
Manchester United
MANU
$4.17B
| $440K | ﹤0.01% |
33,176
+18,552
| +127% | +$232K |
|
|
HAIA
4320
DELISTED
Healthcare AI Acquisition Corp. Class A Ordinary Shares
HAIA
| $440K | ﹤0.01% |
43,600
| – | – |
|
|
OSG
4321
DELISTED
Overseas Shipholding Group Inc.
OSG
| $440K | ﹤0.01% |
148,079
+64,156
| +76% | +$174K |
|
4322
Alpha Tau Medical
DRTS
$1.32B
| $439K | ﹤0.01% |
75,116
-2,271
| -3% | -$20K |
|
4323
VanEck IG Floating Rate ETF
FLTR
$3.04B
| $438K | ﹤0.01% |
17,635
| – | – |
|
4324
UroGen Pharma
URGN
$2.36B
| $438K | ﹤0.01% |
52,678
+38,619
| +275% | +$319K |
|
4325
CALL
Humana
HUM
$46.7B
| $437K | ﹤0.01% |
900
| – | – |
|
Similar funds
JP Morgan Chase's Q3 2022 Portfolio in Review
As of Q3 2022, JP Morgan Chase held 7,216 positions worth $696B, down 3% from $718B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q3 2022 filing shows 557 new, 2,573 increased, 2,583 reduced and 516 closed positions. Its largest new stake was Franklin FTSE Japan ETF: 3,003,780 shares worth $65.1M. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $1.25B.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q3 2022 buy was Franklin FTSE Japan ETF: 3,003,780 shares worth $65.1M.
- JP Morgan Chase added most to Invesco QQQ Trust in Q3 2022, an estimated $1.97B increase.
- JP Morgan Chase's biggest Q3 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $1.25B.
- JP Morgan Chase fully exited CMC Materials, Inc. Common Stock in Q3 2022, selling an estimated $248M.
- JP Morgan Chase's ten largest holdings make up 17% of its $696B portfolio in Q3 2022.
- JP Morgan Chase opened 557 new positions and closed 516 in Q3 2022.
- JP Morgan Chase's portfolio value fell 3% quarter-over-quarter to $696B.
Based on JP Morgan Chase's 13F filing for Q3 2022, filed 14 Nov 2022.